Immune-mediated liver injury induced by PD-1/PD-L1 checkpoint inhibitors is different from idiosyncratic drug-induced liver injury

被引：0
|
作者：
Wang, Yan [1 ]
Meng, Yao [1 ]
Zhang, Mengmeng [1 ]
Guo, Tiantian [1 ]
Chen, Wei [1 ]
Liu, Liwei [2 ]
Zhao, Xinyan [1 ]
机构：
[1] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Natl Clin Res Ctr Digest Dis,Key Lab Translat Med, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Dept Liver Dis 4, Difficult & Complicated Liver Dis & Artificial Li, Beijing, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-326
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [11] Neoadjuvant PD-1/PD-L1 Immune Checkpoint Inhibitors in Solid Tumors
    Zhao, S.
    Li, X.
    Wang, S.
    Wang, Y.
    Huang, D.
    Da, Y.
    Song, Z.
    Chen, J.
    Manegold, C.
    Peng, L.
    Xu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S651
  • [12] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [13] Profiles of Immune Cells and Reproduction of Immune-mediated Drug-induced Liver Injury
    Fujisaka, Yasuyuki
    Kondo, Yasuteru
    Sasaki, Takamitsu
    Kogure, Takayuki
    Inoue, Jun
    Nakagome, Yu
    Wakui, Yuuta
    Iwata, Tomoaki
    Morosawa, Tatsuki
    Umetsu, Teruyuki
    Suzuki, Hiroyuki
    Yamaguchi, Hiroaki
    Mano, Nariyasu
    Nagata, Kiyoshi
    Shimosegawa, Tooru
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S871 - S871
  • [14] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Baraibar, Iosune
    Melero, Ignacio
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    DRUG SAFETY, 2019, 42 (02) : 281 - 294
  • [15] Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction
    Le Biannic, Raphael
    Magnez, Romain
    Klupsch, Frederique
    Leleu-Chavain, Natascha
    Thiroux, Bryan
    Tardy, Morgane
    El Bouazzati, Hassiba
    Dezitter, Xavier
    Renault, Nicolas
    Vergoten, Gerard
    Bailly, Christian
    Quesnel, Bruno
    Thuru, Xavier
    Millet, Regis
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [16] Idiosyncratic drug-induced liver injury: an overview
    Hussaini, S. Hyder
    Farrington, Elizabeth A.
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (06) : 673 - 684
  • [17] Models of Idiosyncratic Drug-Induced Liver Injury
    Yokoi, Tsuyoshi
    Oda, Shingo
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 : 247 - 268
  • [18] Epidemiology of Idiosyncratic Drug-Induced Liver Injury
    Bell, Lauren N.
    Chalasani, Naga
    SEMINARS IN LIVER DISEASE, 2009, 29 (04) : 337 - 347
  • [19] Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
    Ruiting Li
    Xiaojing Zou
    Huaqing Shu
    You Shang
    Intensive Care Research, 2021, 1 (1-2): : 11 - 15
  • [20] EARLY DEVELOPMENT OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY IN AN IMPAIRED IMMUNE CHECKPOINT MOUSE MODEL
    Jee, Alison
    Uetrecht, Jack
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S59 - S59
12345